Results

Total Results: 1,549 records

Showing results for "drugs".

81. Evaluation of a Wireless Handheld Medication Management Device in the Prevention of Drug-Drug Interactions in a Medicaid Population (pdf file)
    digital.ahrq.gov/sites/default/files/docs/library/33-45.pdf
    February 01, 2012 - of Managed Care Pharmacy 33 • Medication knowledge deficiency, including knowledge about drugs … widely prescribed potential DDIs included those involving warfarin with nonsteroidal anti-inflammatory drugs … Baseline Number of pDDIs Follow-Up Number of Object Drugs Follow-Up % Changeb Number … of pDDIs Baseline Number of Object Drugs Baseline Number of pDDIs Follow-Up Number … of Object Drugs Follow-Up % Changeb Warfarin-NSAIDs 5,181 25,646 3,451 25,383 -32.7 1,160 6,494

82. West Virginia Medical Institute: Using IT to Improve Patient Safety in Small, Rural Hospitals | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/ahrq-funded-projects/past-initiatives/transforming-healthcare-quality-through-health-it/west-virginia-medical
    September 29, 2007 - Regional Medical Center, agreed to participate in a pilot project that would record the use of "rescue drugs … pharmacy every two weeks produced a list of patients who received one of eight commonly used rescue drugs

83. Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS) (pdf file)
    digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf
    January 01, 2011 - Adverse events from drugs and vaccines are common, but underreported. … Low reporting rates preclude or slow the identification of “problem” drugs and vaccines that endanger … and other information systems has the potential to speed the identification of problems with new drugs … and more careful quantification of the risks of older drugs.

84. Clinical decision support for drug-drug interactions: improvement needed. | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/citation/cds-drug-drug-interactions
    January 01, 2023 - Clinical decision support for drug-drug interactions: improvement needed. Citation Horn JR, Gumpper KF, Hardy JC, et al. Clinical decision support for drug-drug interactions: improvement needed. Am J Health Syst Pharm 2013 May 15;70(10):905-9. Link http://www.ncbi.nlm.nih.gov/pubmed/23640353 …

85. National rules for drug-drug interactions: are they appropriate for tertiary hospitals? | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/citation/national
    January 01, 2023 - National rules for drug-drug interactions: are they appropriate for tertiary hospitals? Citation Cho I, Lee JH, Choi J, et al. National rules for drug-drug interactions: are they appropriate for tertiary hospitals? J Korean Med Sci 2016 Dec;31(12):1887-96. PMID: 27822925. Link https://www.ncbi…

86. Improving the specificity of drug-drug interaction alerts: Can it be done? | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/improving
    January 01, 2023 - Improving the specificity of drug-drug interaction alerts: Can it be done? Citation Reese T, Wright A, Liu S, Boyce R, Romero A, Del Fiol G, Kawamoto K, Malone D. Improving the specificity of drug-drug interaction alerts: Can it be done? Am J Health Syst Pharm. 2022 Jun 23;79(13):1086-1095. doi: 10.10…

87. Creating Meaningful Decision Support to Reduce Drug-Drug Interactions | Digital Healthcare Research
    digital.ahrq.gov/program-overview/research-stories/creating-meaningful-decision-support-reduce-drug-drug
    January 01, 2023 - Creating Meaningful Decision Support to Reduce Drug-Drug Interactions Theme: Optimizing Care Delivery for Clinicians Subtheme: Optimizing Patient Safety Using Digital Healthcare Solutions By individualizing drug–drug interaction alerts to individual patient circumstances, providers can …

88. Expert Clinical Decision Support Systems to Enhance Antimicrobial Stewardship Programs: Insights from the Society of Infectious Diseases Pharmacists | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-bibliography/clinical-decision-support-systems-cdss/expert
    place tremendous burdens on the health care system and create situations for misuse of antimicrobial drugs

89. Cost savings using a stepped-care prescribing protocol for nonsteroidal anti-inflammatory drugs | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/cost-savings-using-stepped-care
    March 27, 1996 - Cost savings using a stepped-care prescribing protocol for nonsteroidal anti-inflammatory drugs

90. Health Information Technology and Improving Medication Use - 2011 | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/health-information-technology-and-improving-medication-use/annual-summary/2011
    January 01, 2011 - Patient Reports of Side Effects with Electronic Health Records for Surveillance of Recently Approved Drugs … project is to increase surveillance evidence for recently-released Food and Drug Administration-approved drugs … The team reviewed a large dataset of adverse drug events involving multiple drugs in community hospitals

91. Encoding and Processing Patient Allergy Information in EHRs - Final Report (pdf file)
    digital.ahrq.gov/sites/default/files/docs/citation/r01hs022728-zhou-final-report-2018.pdf
    January 01, 2018 - Epidemiological Studies Using MTERMS, we were able to describe the epidemiology of drugs allergies, … Drug-Induced Anaphylaxis Although drugs represent a common cause of anaphylaxis, few large studies of … Hypersensitivity Reactions Hypersensitivity reactions (HSRs) are immunologic responses to drugs. … Causative drugs and drug groups were assessed. … Contrast Allergen Documentation in the EHR We systematically identified medical imaging drugs and class

92. Meaningful Drug Interaction Alerts – Final Report (pdf file)
    digital.ahrq.gov/sites/default/files/docs/citation/r01hs025984-malone-final-report-2023.pdf
    January 01, 2023 - We extracted the list of drugs in each interacting group and variables that can affect the risk or … Controls consisted of patients receiving other disease modifying rheumatic drugs. … Of the 23-drug average per group, an average of 3.8 drugs per group were the same across references. … Drug interactions involving drugs used to treat COVID-19 (date 5/13/2020) 10. … Drugs Real World Outcomes. 2022 Sep;9(3):415-423. doi: 10.1007/s40801-022-00307-5.

93. The impact of hospitalwide computerized physician order entry on medical errors in a pediatric hospital | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/impact-hospitalwide-computerized
    January 01, 2005 - Drugs were cross-referenced in an online formulary.

94. Costs associated with developing and implementing a computerized clinical decision support system for medication dosing for patients with renal insufficiency in the long-term care setting | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-bibliography/long-term-care/costs-associated-developing-and
    The team required 924.5 hours and $48,668.57 in estimated costs to develop 94 alerts for 62 drugs.

95. Health Information Technology and Improving Medication Use (pdf file)
    digital.ahrq.gov/sites/default/files/docs/activity/2011_016970_bates_pdf_3.pdf
    January 01, 2011 - Patient Reports of Side Effects with Electronic Health Records for Surveillance of Recently Approved Drugs … therapeutiCs (Certs) program (u18) evidence for recently-released Food and Drug Administration-approved drugs … The team reviewed a large dataset of adverse drug events involving multiple drugs in community hospitals

96. Prescribers' Responses to Alerts During Medication Ordering in the Long Term Care Setting | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-bibliography/electronic-prescribing-erx/prescribers
    January 01, 2006 - For this randomized controlled trial, prescribers ordering drugs for residents on three resident-care

97. Adoption of electronic prescribing in community-based practices (pdf file)
    digital.ahrq.gov/sites/default/files/docs/AHRQ_Webinar_Aug_2009_Med_Mgmt.pdf
    January 01, 2009 - Qualitative data from outpatient setting – Review of medication history, identifying patients on high-risk drugs … EPCS • Pharmaceutical (or drug) diversion is the channeling of licit controlled substances or other pharmaceuticals … prescriptions; doctor shopping; indiscriminate prescribing; and illegal sales of prescriptions and pharmaceuticals … potential benefits unique to EPCS: • Reductions in non-medical use and abuse of federally controlled pharmaceuticals … catchment Systems catchment areaarea • Obtain DEA waiver to allow e-prescribing of Schedule II-V drugs

98. Role of IT in Improving Patient Safety (pdf file)
    digital.ahrq.gov/sites/default/files/docs/page/2006StromPepper_051211comp.pdf
    May 23, 2011 - minimizing adverse drug reactions • Decrease hospital costs by eliminating the inappropriate use of drugs … acceptable low cost substitutions • Decrease liability associated with the inappropriate use of high risk drugs

99. Impact of Office-Based E-Prescribing on Prescribing Processes and Outcomes | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/impact-office-based-e-prescribing-prescribing-processes-and-outcomes
    January 01, 2023 - Research Method: Systematic Review Prior authorization for biologic disease-modifying antirheumatic drugs … Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid

100. PowerPoint Presentation (ppt file)
     digital.ahrq.gov/sites/default/files/docs/page/Root_0.ppt
     June 01, 2005 - November 15-18, 2004 Physician to Hospital Medical necessity; Admissions; pre-natal reports current drugs … nec; Workers Comp notes; P4P Claims; claim status; eligibility, prior auths Formularies, current drugs … eligibility, prior authorizations Drug look-ups Case reporting; RODS Vital records Tumor registries Drugs … E-prescriptions; Questions about tests and results Health Plans Pharmacy eligibility, formularies, current drugs